Brazilian researchers have developed a simple test that almost instantly tells whether a person has been exposed to any of ...
There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...
The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...
Using this cis-activation strategy in primary cells and muscle, we have demonstrated an increase in transgene expression of more than 600-fold from a minimal simian virus 40 (SV40) promoter and an ...
Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...
After figuring out how to grow recombinant bacteria on an industrial scale and how to harvest the insulin they produce, it was time to bring the recombinant insulin to the market. In 1982 Food and ...
The US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™, a recombinant chikungunya vaccine, ...
Janet Mertz’s work with simian virus 40 DNA during her graduate years was pivotal for developing DNA recombination as we now know it. Berg was awarded one-half of the Nobel Prize in Chemistry in 1980 ...
The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% As scientific and technological advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results